학술논문

Effect of a Chikungunya Virus-Like Particle Vaccine on Safety and Tolerability Outcomes: A Randomized Clinical Trial
Document Type
Report
Source
JAMA, The Journal of the American Medical Association. April 14, 2020, Vol. 323 Issue 14
Subject
United States
Language
English
ISSN
0098-7484
Abstract
The safety and tolerability of an investigational Chikungunya virus-like particle vaccine in endemic regions is examined. Results showed that the vaccine was safe, well-tolerated and immunogenic in participants residing in Chikungunya virus-endemic areas.